PRESS RELEASE published on 09/16/2026 at 22:00, 1 month 11 days ago Inside Information / Other news releases Innate Pharma and Sobi partnership becomes effective after meeting closing conditions, triggering USD 75 million payment and commencing TELLOMAK-3 Phase 3 study in Q1 2027 Partnership Innate Pharma Closing Conditions Sobi TELLOMAK-3
BRIEF published on 09/10/2026 at 07:05, 1 month 18 days ago Innate Pharma fournira des informations financières lors de sa prochaine conférence téléphonique. Stratégie D'entreprise Conférence Téléphonique Mise À Jour Financière Innate Pharma Résultats 2026
BRIEF published on 09/10/2026 at 07:05, 1 month 18 days ago Innate Pharma to Provide Financial Insights in Upcoming Conference Call Conference Call Business Strategy Financial Update Innate Pharma 2026 Results
BRIEF published on 09/10/2026 at 07:05, 1 month 18 days ago Innate Pharma annonce une conférence sur ses résultats semestriels Résultats Financiers Immunothérapie Conférence Téléphonique Partenariats Biopharmaceutiques Innate Pharma
BRIEF published on 09/10/2026 at 07:05, 1 month 18 days ago Innate Pharma announces a conference on its half-year results Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
PRESS RELEASE published on 09/10/2026 at 07:00, 1 month 18 days ago Inside Information / Other news releases Innate Pharma to host conference call on September 17, 2026, providing first half 2026 financial results and business update. Event details available on www.innate-pharma.com Financial Results Conference Call Biotechnology Business Update Innate Pharma
PRESS RELEASE published on 09/10/2026 at 07:00, 1 month 18 days ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique et un webcast le 17 septembre pour présenter ses résultats financiers et son activité au premier semestre 2026 Résultats Financiers Webcast Conférence Téléphonique Innate Pharma Immunothérapies
BRIEF published on 08/14/2026 at 11:35, 2 months 13 days ago Innate Pharma Announces Upcoming Conference Call and Webcast Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
BRIEF published on 08/14/2026 at 11:35, 2 months 13 days ago Innate Pharma annonce une conférence téléphonique et une webdiffusion à venir Biotechnologie Immunothérapie Webdiffusion Conférence Téléphonique Innate Pharma
PRESS RELEASE published on 08/14/2026 at 11:30, 2 months 13 days ago Inside Information / Other news releases Innate Pharma to host conference call and webcast with key executives discussing latest updates. Event details available on company website Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
Published on 10/28/2026 at 08:00, 1 hour 12 minutes ago Algo Grande Copper Makes New Skarn Discovery at Adelita; Step-Out Hole AG-CG-PH2-003 Returns a Combined 139.81 Metres of 1.3% CuEq from Cerro Grande and the New Margarita Skarn
Published on 10/28/2026 at 02:55, 6 hours 17 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 6 hours 22 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 9 hours 32 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 9 hours 47 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/28/2026 at 09:05, 7 minutes ago Rivermate recognized as a key provider of EoR solutions in Everest Group's Employer of Record (EoR) Solutions PEAK Matrix® Assessment 2026
Published on 10/28/2026 at 09:00, 12 minutes ago Municipality Finance issues a GBP 30 million tap under its MTN programme
Published on 10/28/2026 at 09:00, 12 minutes ago PFISTERER Kontaktsysteme GmbH improves its sustainability rating and ranks among the top 3 percent of its industry
Published on 10/28/2026 at 08:00, 1 hour 12 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 1 hour 12 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 15 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 15 hours 12 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
